文献速递免疫规划

三种单纯疱疹病毒2型疫苗候选株经外周或黏膜接种途径的直接比较

Direct comparison of three herpes simplex virus-2 vaccine candidates using peripheral or mucosal routes of vaccination.
PubMed 文献 · Vaccine · 2026-02-01

研究在小鼠模型中比较了三种HSV-2突变病毒疫苗(复制缺陷型、单周期复制型、复制 competent 型)经五种接种途径(肌内、两处皮下、直肠内、阴道内)对阴道攻击的保护效果。结果显示,复制 competent 型疫苗经阴道内接种保护最佳,可完全预防疾病且90%动物攻击后无检出排毒,尽管血清中和滴度很低;经直肠内接种也优于其他疫苗但不及阴道内。经颈部皮下接种时复制缺陷型更有效,肌内接种时复制缺陷型也倾向于优于活疫苗。肌内接种复制缺陷型和单周期复制型疫苗诱导的血清中和抗体水平最高。

要点

  • 复制 competent 型HSV-2疫苗经阴道内接种可完全预防小鼠发病,90%无排毒。
  • 阴道内接种复制 competent 型疫苗的保护效果优于复制缺陷型和单周期复制型。
  • 经颈部皮下接种时复制缺陷型疫苗比复制 competent 型更有效。

核心结论

  • 经阴道内接种复制 competent 型HSV-2疫苗对生殖道感染的保護優於复制缺陷型和单周期复制型疫苗。

研究设计与样本

  • 在小鼠模型中比较三种HSV-2突变病毒疫苗(复制缺陷型、单周期复制型、复制 competent 型)经五种接种途径(肌内、两处皮下、直肠内、阴道内)对阴道攻击的保护效果。

主要发现

  • 阴道内接种复制 competent 型疫苗后完全预防疾病,90%动物攻击后无检出排毒,尽管血清中和滴度很低。
  • 直肠内接种复制 competent 型疫苗也优于其他疫苗,但效果不及阴道内接种。
  • 颈部皮下接种时复制缺陷型疫苗比复制 competent 型更有效,肌内接种时复制缺陷型也倾向于优于活疫苗。
  • 肌内接种复制缺陷型和单周期复制型疫苗诱导的血清中和抗体水平最高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite decades of research, no vaccine has been approved for herpes simplex virus-2 (HSV-2). While HSV-2 subunit vaccines have been more extensively studied, various HSV-2 mutants have also been tested. We compared three types of HSV-2 mutant viruses (replication-defective, single-cycle replication, and replication-competent) using five routes of vaccination (intramuscular, subcutaneous at two different sites, intrarectal, or intravaginal) for their ability to protect mice from intravaginal challenge with HSV-2. The replication-competent virus vaccine gave the best protection compared to the other vaccines after intravaginal vaccination of mice resulting in complete prevention of disease, and 90 % of the animals had no detectable shedding after challenge despite very low serum neutralizing titers. The replication-competent virus vaccine was also superior to the other vaccines when given intrarectally, although less effective than when given intravaginally. In contrast, when given subcutaneously in the scruff of the neck, the replication-defective vaccine was more effective than the replication-competent vaccine and the replication-defective vaccine tended to be more effective than the live vaccine when given intramuscularly. The highest levels of serum neutralizing antibody were observed with the replication-defective and single-cycle replication vaccines given intramuscularly. Thus, excellent protection from genital herpes was obtained after intravaginal vaccination with the replication-competent vaccine providing evidence that a replication-competent vaccine given by the natural route of HSV-2 infection is superior to replication-defective or single-cycle replication vaccines to reduce virus infection and spread in the genital mucosa.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wang K, Jordan T, Suzuki-Williams L, et al. Direct comparison of three herpes simplex virus-2 vaccine candidates using peripheral or mucosal routes of vaccination. Vaccine. 2026. PMID: 41628523. doi:10.1016/j.vaccine.2025.128107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。